SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Alnylam Initiates Rolling Submission of New Drug Application To FDA For Lumasiran For Treatment Of Primary Hyperoxaluria Type 1

Benzinga · -